Personalis, Inc. (PSNL) Q2 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Personalis, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.914 Good day and welcome to the Personale's 00:00:02.914 -- 00:00:06.618 second quarter 2024 earnings conference call. 00:00:06.618 -- 00:00:10.082 All participants will be in listen-only mode. 00:00:10.082 -- 00:00:15.107 After today's presentation, there will be an opportunity to ask questions. 00:00:15.107 -- 00:00:18.771 Please note that this event is being recorded. 00:00:18.771 -- 00:00:23.596 I would now like to turn the call over to Caroline Corner, Investor Relations. 00:00:23.596 -- 00:00:26.176 Please go ahead. 00:00:26.599 -- 00:00:31.650 Thank you, Operator. Welcome to PersonAlyssa's second quarter 2024 earnings call. 00:00:31.650 -- 00:00:37.217 Joining today's call are Chris Hall, Chief Executive Officer and President, Erin Toshibana, 00:00:37.217 -- 00:00:41.683 Chief Financial and Chief Operating Officer, and Rich Chen, Chief Medical Officer and 00:00:41.683 -- 00:00:46.630 EVP R&D. All statements made on this call do not relate to matters of historical fact, 00:00:46.630 -- 00:00:50.034 should be considered forward-looking statements within the meaning of U.S. 00:00:50.034 -- 00:00:54.200 securities laws. For example, any statements regarding trends and expectations for our 00:00:54.200 -- 00:00:59.245 financial performance this year and longer term, cash runway, revenue expectations and 00:00:59.245 -- 00:01:05.112 timing, reimbursement goals, size and booking of orders, products, services, technology, 00:01:05.112 -- 00:01:09.436 clinical milestones, the outcome and timing of reimbursement decisions, expectations 00:01:09.436 -- 00:01:14.281 for existing and future collaboration activities, cost expectations, our market opportunity, 00:01:14.281 -- 00:01:18.406 and business outlook. These statements are subject to r...